DAO prepress abstract   -  DOI: https://doi.org/10.3354/dao03817

ABSTRACT: Acute hepatopancreatic necrosis disease (AHPND) is a devastating shrimp disease caused by a binary toxin, PirAB, produced by Vibrio parahaemolyticus and other closely related bacteria. To address AHPND, over three hundred unique single domain antibodies (also known as nanobodies) derived from the V_HH domains of Lama glama heavy chain only antibodies were raised against either PirA or PirB and characterized. Nanobodies were shortlisted based on their affinities for either PirA or PirB, their relative stability in intestinal fluids, and their ability to reduce PirAB-induced death in brine shrimp (Artemia salina). From these data, a subset of nanobodies were tested for their ability to reduce AHPND in whiteleg shrimp (Litopenaeus vannamei) and nanobodies targeting either PirA or PirB provided significant disease protection to whiteleg shrimp. These results show that nanobodies can be a new option for shrimp farmers to reduce or eliminate the impact of AHPND on their operations.